Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/26247
Title: Human papillomavirus genotype and viral load agreement between paired first-void urine and clinician-collected cervical samples
Authors: Van Keer, Severien
Tjalma, Wiebren A. A.
Pattyn, Jade
Biesmans, Samantha
Pieters, Zoë 
Van Ostade, Xaveer
Ieven, Margareta
Van Damme, Pierre
Vorsters, Alex
Issue Date: 2018
Source: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 37(5), p. 859-869
Abstract: The performance and acceptability of first-void urine as specimen for the detection of HPV DNA in a Belgian referral population was evaluated using an optimized sample collection and processing protocol. One hundred ten first-void urine and cervical samples were collected from 25- to 64-year-old women who were referred for colposcopy (January-November 2016). Paired samples were analyzed by the Riatol qPCR HPV genotyping assay. Acceptability data were gathered through questionnaires (NCT02714127). A higher high-risk HPV DNA prevalence was observed in first-void urine (n = 76/110) compared to cervical samples (n = 73/110), with HPV31 and HPV16/31 being most prevalent correspondingly. For both any and high-risk HPV DNA, good agreement was observed between paired samples (Cohen's Kappa of 0.660 (95% CI: 0.486-0.833) and 0.688 (95% CI: 0.542-0.835), respectively). In addition, significant positive correlations in HPV copies (per microliter of DNA extract) between paired samples were observed for HPV16 (r(s) = 0.670; FDR (false discovery rate)-adjusted p = 0.006), HPV18 (r(s) = 0.893; FDR-adjusted p = 0.031), HPV31 (r(s) = 0.527; FDR-adjusted p = 0.031), HPV53 (r(s) = 0.691; FDR-adjusted p = 0.017), and HPV68 (r(s) = 0.569; FDR-adjusted p = 0.031). First-void urine sampling using a first-void urine collection device was preferred over a clinician-collected cervical sample. And mostly, first-void urine sampling at home was favored over collection at the clinic or the general practitioner's office. First-void urine sampling is a highly preferred, non-invasive method that ensures good agreement in HPV DNA (copies) with reference cervical samples. It is particularly interesting as a screening technique to reach non-participants, and its clinical performance should be further evaluated.
Notes: Van Keer, S (reprint author), Univ Antwerp, CEV, Vaccine & Infect Dis Inst VAXINFECTIO, Fac Med & Hlth Sci, Univ Pl 1, B-2610 Antwerp, Belgium. severien.vankeer@uantwerpen.be
Document URI: http://hdl.handle.net/1942/26247
ISSN: 0934-9723
e-ISSN: 1435-4373
DOI: 10.1007/s10096-017-3179-1
ISI #: 000430981900007
Rights: Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http:// creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Category: A1
Type: Journal Contribution
Validations: ecoom 2019
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
van keer 2.pdfPublished version922.76 kBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

7
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

19
checked on May 14, 2022

Page view(s)

54
checked on May 15, 2022

Download(s)

96
checked on May 15, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.